China · Delayed Price · Currency is CNY Kexing Biopharm Company Description
Kexing Biopharm Co., Ltd. engages in the research and development, production, and sale of recombinant protein drugs and microbial preparations in China and internationally.
The company focuses on pharmaceutical research in the therapeutic fields of antiviral, tumor and immunity, blood, digestion, and degenerative diseases.
Its products include recombinant human interferon α1b, human erythropoietin, and human granulocyte stimulating factor; Clostridium butyricum combined live bacteria powder; Kehuang Capsule, a Chinese patent medicine; Entecavir, a chemical drug; and liraglutide, a human glucagon-like peptide-1, as well as Albumin-Paclitaxel, Infliximab, Bevacizumab, adalimumab, trastuzumab, neratinib maleate tablets, and lenalidomide capsules.
The company was founded in 1989 and is based in Jinan, China.
| Country | China |
| Founded | 1989 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 947 |
| CEO | Yanqing Zhao |
Contact Details
Address: No. 2666 Chuangye Road Jinan, 250200 China | |
| Phone | 86 40 0888 9496 |
| Website | kexing.com |
Stock Details
| Ticker Symbol | 688136 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Yanqing Zhao | GM and Director |
| Xiaoqin Wang | Chief Financial Officer, Secretary to the Board and Director |
| Ning Cui | Deputy GM and Director |
| Suofu Qin | Deputy General Manager |
| Ke Shao | Deputy General Manager |
| Hongjie Ma | Deputy General Manager |